Back to Companies
SELLAS Life Sciences Group, Inc.
SLSNasdaqCIK: 0001390478
Over the 11 most recent insider filings, SELLAS Life Sciences Group, Inc. (SLS) has seen activity from 7 distinct insiders — 1 buying and 3 selling. The activity is heavily weighted toward selling: $100.8K bought versus $716.7K sold, net sales of $615.9K. Stergiou Angelos M. (President and CEO, Director) is the most active by dollar volume, and the single largest transaction was $510.2K by Stergiou Angelos M.. All figures are drawn from official SEC Form 3, 4, and 5 disclosures and update as new filings arrive.
Total Volume
$1.2M
Purchases
$100.8K
Sales
$716.7K
Unique Insiders
7
Recent Insider Trades
11 loaded
| Nov 20 | SLS SELLAS Life Sciences Group, Inc. | CICIC DRAGAN | SVP, Chief Development Officer | Sell | $133.0K |
| Nov 20 | SLS SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | President and CEO, Director | Sell | $510.2K |
| Nov 20 | SLS SELLAS Life Sciences Group, Inc. | Burns John Thomas | CFO | Sell | $73.5K |
| Jun 18 | SLS SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | President and CEO, Director | Grant | $0 |
| Jan 9 | SLS SELLAS Life Sciences Group, Inc. | CICIC DRAGAN | SVP, Chief Development Officer | Grant | $0 |
| Jan 9 | SLS SELLAS Life Sciences Group, Inc. | VAN NOSTRAND ROBERT L | Director | Grant | $0 |
| Jan 9 | SLS SELLAS Life Sciences Group, Inc. | Varian John | Director | Grant | $0 |
| Jan 9 | SLS SELLAS Life Sciences Group, Inc. | SCHEINBERG DAVID A | Director | Grant | $0 |
| Dec 5 | SLS SELLAS Life Sciences Group, Inc. | CICIC DRAGAN | SVP, Chief Development Officer | Other | $95.7K |
| Dec 5 | SLS SELLAS Life Sciences Group, Inc. | Stergiou Angelos M. | President and CEO, Director | Other | $280.6K |
| Nov 21 | SLS SELLAS Life Sciences Group, Inc. | Kalin Katherine Bach | Director | Buy | $100.8K |
11 filings